natural compound library

The unparalleled chemical diversity of natural products makes them an ideal choice for screening active small molecules. Natural products is always a significant source in drug discovery. According to authoritative statistics, 79 out of 99 small molecule anticancer drugs have been successfully developed based on natural products since 1981. Natural products have demonstrated successful modulation of isolated but crucial targets, especially in antimicrobial targets and protein interactions. Many researchers consider natural products and their derivatives as unique tools for studying and manipulating protein function. The Drug-like Natural Compound Library comprises 522 novel molecules, serving as a complement to the L6000 Natural Product Library. This library enhances the probability of successful drug screening, making it an excellent tool for lead compound discovery.

A unique collection of 4221 natural products for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 4654 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of 800 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 500 natural alkaloids can be used for high throughput and high content screening;

A unique collection of 536 flavonoids can be used for high throughput and high content screening;

A unique collection of 719 natural terpenes and terpenoids can be used for high throughput and high content screening;

A unique collection of 945 saccharides and glycosides compounds can be used for HTS and HCS;

A unique collection of 144 marine natural products for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1812 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 23618 pure natural products with diverse structures and sources covering various plant, animal, and microbe species;

Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening.

A unique collection of 2534 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening;

A unique collection of 489 microbial natural products for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 938 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 176 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2270 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study;

A unique collection of 425 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.

A unique collection of 3163 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS);

A collection of 1321 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study;

The library consists of 3745 members belonging 22 scaffolds (average 180 compounds per scaffold).

A unique collection of 573 cancer cell differentiation inducing compounds for high throughput and high content screening;